Combining active ingredients to treat depression in the wake of COVID-19

Melanie A. Abas

doi:10.1016/S2215-0366(21)00436-3

Combining active ingredients to treat depression in the wake of COVID-19

Melanie A. Abas

King's College London

Research output: Contribution to journal › Comment/debate › peer-review

4 Citations (Scopus)

Original language	English
Pages (from-to)	190-191
Number of pages	2
Journal	The Lancet Psychiatry
Volume	9
Issue number	3
DOIs	https://doi.org/10.1016/S2215-0366(21)00436-3
Publication status	Published - Mar 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S2215-0366(21)00436-3

Cite this

@article{aa192d9d0da0456d9558fbbfaf1c9bed,

title = "Combining active ingredients to treat depression in the wake of COVID-19",

author = "Abas, {Melanie A.}",

year = "2022",

month = mar,

doi = "10.1016/S2215-0366(21)00436-3",

language = "English",

volume = "9",

pages = "190--191",

journal = "The Lancet Psychiatry",

issn = "2215-0366",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Combining active ingredients to treat depression in the wake of COVID-19

AU - Abas, Melanie A.

PY - 2022/3

Y1 - 2022/3

UR - http://www.scopus.com/inward/record.url?scp=85122960224&partnerID=8YFLogxK

U2 - 10.1016/S2215-0366(21)00436-3

DO - 10.1016/S2215-0366(21)00436-3

M3 - Comment/debate

C2 - 34895478

AN - SCOPUS:85122960224

SN - 2215-0366

VL - 9

SP - 190

EP - 191

JO - The Lancet Psychiatry

JF - The Lancet Psychiatry

IS - 3

ER -

Combining active ingredients to treat depression in the wake of COVID-19

UN SDGs

Access to Document

Other files and links

Cite this